Jason Tardio

Insider Reports History

Entity
Individual
Location
1460 Broadway, New York, NY
Signature
/s/ Evan Janssens for Jason Tardio by PoA
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jason Tardio:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Ovid Therapeutics Inc. Chief Operating Officer Common Stock 28.1K $60.5K $2.15 Feb 22, 2024 Direct
IMMUNIC, INC. President and COO Stock Option 500K Jul 12, 2024 Direct
Ovid Therapeutics Inc. Chief Operating Officer Stock Option (Right to Buy) 169K Feb 22, 2024 Direct
IMMUNIC, INC. President and COO Stock Option 158K Dec 4, 2024 Direct

Insider Reports Filed by Jason Tardio

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IMUX IMMUNIC, INC. Dec 4, 2024 1 $0 4 Dec 6, 2024 President and COO
IMUX IMMUNIC, INC. Jul 12, 2024 1 $0 4 Jul 12, 2024 President and COO
IMUX IMMUNIC, INC. Jul 12, 2024 0 $0 3 Jul 12, 2024 President and COO
OVID Ovid Therapeutics Inc. Feb 22, 2024 2 $0 4 Feb 26, 2024 Chief Operating Officer
OVID Ovid Therapeutics Inc. Feb 23, 2023 1 $0 4 Feb 27, 2023 Chief Operating Officer
OVID Ovid Therapeutics Inc. Sep 12, 2022 1 -$37.3K 4 Sep 14, 2022 Chief Operating Officer
OVID Ovid Therapeutics Inc. Apr 8, 2022 2 $0 4 Apr 12, 2022 Chief Operating Officer
OVID Ovid Therapeutics Inc. Feb 3, 2022 1 $0 4 Feb 4, 2022 Chief Operating Officer
OVID Ovid Therapeutics Inc. Jul 1, 2021 1 $0 4 Jul 1, 2021 Chief Commercial Officer